MX9207395A - Tiazoles novedosos. - Google Patents

Tiazoles novedosos.

Info

Publication number
MX9207395A
MX9207395A MX9207395A MX9207395A MX9207395A MX 9207395 A MX9207395 A MX 9207395A MX 9207395 A MX9207395 A MX 9207395A MX 9207395 A MX9207395 A MX 9207395A MX 9207395 A MX9207395 A MX 9207395A
Authority
MX
Mexico
Prior art keywords
lower alkyl
novel
tiazoles
hydrogen
alk
Prior art date
Application number
MX9207395A
Other languages
English (en)
Inventor
Martin Missbach
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MX9207395A publication Critical patent/MX9207395A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Tiazoles novedosos de la fórmula (I) en donde R1 y R4 son alquilo inferior, alqu-2-en-1-ilo inferior o alqu-2-in-1-ilo inferior; R2 y R3 son cada una, independientemente de la otra, hidrógeno o alquilo inferior, o forman juntas alquilideno inferior; y R5 y R6 son cada una hidrógeno o alquilo inferior o forman juntas oxo; y R5' y R6' tienen las mismas definiciones que R5 y R6; con la condición de que por lo menos uno de los pares de sustituyentes R5 y R6 y R5' y R6' forman juntas oxo y sus sales; procesos para la preparación de dichos compuestos, composiciones farmacéuticas que los comprenden y sus uso como ingredientes activos medicinales.
MX9207395A 1991-12-18 1992-12-17 Tiazoles novedosos. MX9207395A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH375091 1991-12-18

Publications (1)

Publication Number Publication Date
MX9207395A true MX9207395A (es) 1993-07-01

Family

ID=4262692

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9207395A MX9207395A (es) 1991-12-18 1992-12-17 Tiazoles novedosos.

Country Status (12)

Country Link
US (1) US5399576A (es)
EP (1) EP0548017A1 (es)
JP (1) JPH05255289A (es)
AU (1) AU3018492A (es)
CA (1) CA2085532A1 (es)
FI (1) FI925722A (es)
HU (1) HUT65474A (es)
IL (1) IL104120A0 (es)
MX (1) MX9207395A (es)
NO (1) NO924900L (es)
TW (1) TW213453B (es)
ZA (1) ZA929762B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU664084B2 (en) * 1992-06-03 1995-11-02 Ciba-Geigy Ag Novel thiosemicarbazonic acid esters
US5958683A (en) * 1994-03-30 1999-09-28 Novartis Corporation Screening method using the RZR receptor family
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
AU1304601A (en) * 1999-11-11 2001-06-06 Kyorin Pharmaceutical Co. Ltd. Solid preparations for oral use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1325061A (en) * 1970-07-03 1973-08-01 Ciba Geigy Ag Process for the production of azines
AR204619A1 (es) * 1973-02-13 1976-02-20 Ciba Geigy Ag Procedimiento para la elaboracion de un nuevo derivado de 2,2-azina-2,4-tiazolidindiona
DE2632745A1 (de) * 1975-08-06 1977-02-24 Ciba Geigy Ag 1,1'-dithiobis-(formamid-hydrazone)
JPS57136579A (en) * 1981-01-21 1982-08-23 Mitsui Toatsu Chem Inc Thiazolylurea derivative, its preparation, and pharmaceutical composition containing the same
EP0069154B1 (en) * 1981-01-13 1986-10-15 Mitsui Toatsu Kagaku Kabushiki Kaisha Novel thiazole compounds, process for their preparation, and medicinal composition containing same
DE3941438A1 (de) * 1989-12-15 1991-06-20 Hoechst Ag Neue 2-substituierte 4-(3-alkyl-5-tert.-butyl-4-hydroxy-phenyl)-thiazole, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
EP0691154A1 (en) * 1994-07-07 1996-01-10 The Boc Group, Inc. Purification of nitric oxide

Also Published As

Publication number Publication date
IL104120A0 (en) 1993-05-13
ZA929762B (en) 1993-06-18
HUT65474A (en) 1994-06-28
HU9204002D0 (en) 1993-04-28
NO924900D0 (no) 1992-12-17
AU3018492A (en) 1993-07-01
FI925722A (fi) 1993-06-19
US5399576A (en) 1995-03-21
JPH05255289A (ja) 1993-10-05
TW213453B (es) 1993-09-21
FI925722A0 (fi) 1992-12-16
NO924900L (no) 1993-06-21
EP0548017A1 (de) 1993-06-23
CA2085532A1 (en) 1993-06-19

Similar Documents

Publication Publication Date Title
SE8300736D0 (sv) Novel pharmacologically active compounds
ES2053451T3 (es) Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
YU47116B (sh) Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2118835T3 (es) 2-etil-1h-imidazo(4,5-c)quinolin-4-aminas antiviricas.
FR2698543B1 (fr) Nouvelles compositions à base de taxoides.
ATE124401T1 (de) Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel.
SE8505112D0 (sv) Novel pharmacological compounds
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
FI865233A0 (fi) Pyrazolinderivat, deras framstaellning och anvaendning som medel med insekticid och akaricid verkan.
ES2158413T3 (es) Alquenoilguanididas sustituidas con fenilo, procedimiento para su preparacion, su uso como farmacos o en agentes de diagnostico y medicamentos que las contienen.
DE3583916D1 (de) Waessrige arzneiformulierungen des piroxicammonohydrats.
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
SE8404065D0 (sv) Novel biologically active compounds
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ATE70056T1 (de) Oxopyrimidin-derivate und sie enthaltende pharmazeutische zubereitungen.
ATE92036T1 (de) Kardiovaskulaer aktive verbindungen.
MX9207395A (es) Tiazoles novedosos.
FI803202L (fi) Fosfonohydroxiaettiksyra foerfarande foer dess framstaellning och dess anvaendning saosom laekemedel
MX9207396A (es) Imidazoles novedosos.
ES2071458T3 (es) Nuevos compuestos amidicos de 1-(alcoxi-bencil)-piperacinas, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
ES2095431T3 (es) N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
IT1216104B (it) Peptidi ad attivita' farmaceutica.
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
ES2106866T3 (es) Nuevos derivados de 2h-benzo(b)pirano sustituidos en la posicion 4 por arilo o n-heteroarilo, procedimiento para su preparacion y su uso, asi como preparados que contienen los compuestos.